Your browser doesn't support javascript.
loading
Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity.
Morigny, Pauline; Houssier, Marianne; Mairal, Aline; Ghilain, Claire; Mouisel, Etienne; Benhamed, Fadila; Masri, Bernard; Recazens, Emeline; Denechaud, Pierre-Damien; Tavernier, Geneviève; Caspar-Bauguil, Sylvie; Virtue, Sam; Sramkova, Veronika; Monbrun, Laurent; Mazars, Anne; Zanoun, Madjid; Guilmeau, Sandra; Barquissau, Valentin; Beuzelin, Diane; Bonnel, Sophie; Marques, Marie; Monge-Roffarello, Boris; Lefort, Corinne; Fielding, Barbara; Sulpice, Thierry; Astrup, Arne; Payrastre, Bernard; Bertrand-Michel, Justine; Meugnier, Emmanuelle; Ligat, Laetitia; Lopez, Frédéric; Guillou, Hervé; Ling, Charlotte; Holm, Cecilia; Rabasa-Lhoret, Remi; Saris, Wim H M; Stich, Vladimir; Arner, Peter; Rydén, Mikael; Moro, Cedric; Viguerie, Nathalie; Harms, Matthew; Hallén, Stefan; Vidal-Puig, Antonio; Vidal, Hubert; Postic, Catherine; Langin, Dominique.
Afiliação
  • Morigny P; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Houssier M; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Mairal A; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Ghilain C; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Mouisel E; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Benhamed F; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Masri B; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Recazens E; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Denechaud PD; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Tavernier G; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Caspar-Bauguil S; Institut National de la Santé et de la Recherche Médicale (Inserm), U1016, Institut Cochin, Paris, France.
  • Virtue S; Centre National de la Recherche Scientifique (CNRS), UMR 8104, Paris, France.
  • Sramkova V; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Monbrun L; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Mazars A; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Zanoun M; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Guilmeau S; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Barquissau V; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Beuzelin D; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Bonnel S; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Marques M; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Monge-Roffarello B; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Lefort C; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Fielding B; Toulouse University Hospitals, Laboratory of Clinical Biochemistry, Toulouse, France.
  • Sulpice T; University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
  • Astrup A; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Payrastre B; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Bertrand-Michel J; Department for the Study of Obesity and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Meugnier E; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France.
  • Ligat L; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Lopez F; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Guillou H; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Ling C; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Holm C; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Rabasa-Lhoret R; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Saris WHM; Institut National de la Santé et de la Recherche Médicale (Inserm), U1016, Institut Cochin, Paris, France.
  • Stich V; Centre National de la Recherche Scientifique (CNRS), UMR 8104, Paris, France.
  • Arner P; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Rydén M; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Moro C; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Viguerie N; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Harms M; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Hallén S; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Vidal-Puig A; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
  • Vidal H; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France.
  • Postic C; Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
  • Langin D; University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
Nat Metab ; 1(1): 133-146, 2019 01.
Article em En | MEDLINE | ID: mdl-32694809
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Esterol Esterase / Adipócitos / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Insulina Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Nat Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Esterol Esterase / Adipócitos / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Insulina Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Nat Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França